Similarly, SOX2 and NANOG expression were both significantly associated with lymph node metastasis (P < 0.01) and advanced AJCC stage (P = 0.016 and P = 0.031, respectively) (Table 2). This evidence concerns the gene SOX2 and metastatic malignant neoplasm in the lymph nodes.